The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH anlogue therapy not restored by dihydrotestosterone administration (2004)
- Authors:
- USP affiliated authors: ARNHOLD, IVO JORGE PRADO - FM ; MENDONCA, BERENICE BILHARINHO DE - FM
- Unidade: FM
- DOI: 10.1111/j.1365-2265.2004.01930.x
- Assunto: ENDOCRINOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Clinical Endocrinology
- Volume/Número/Paginação/Ano: v. 60, p. 36-40, 2004
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
JORGE, Alexander A. L. et al. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH anlogue therapy not restored by dihydrotestosterone administration. Clinical Endocrinology, v. 60, p. 36-40, 2004Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2004.01930.x. Acesso em: 28 mar. 2024. -
APA
Jorge, A. A. L., Souza, S. C. A. L., Arnhold, I. J. P., & Mendonça, B. B. (2004). The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH anlogue therapy not restored by dihydrotestosterone administration. Clinical Endocrinology, 60, 36-40. doi:10.1111/j.1365-2265.2004.01930.x -
NLM
Jorge AAL, Souza SCAL, Arnhold IJP, Mendonça BB. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH anlogue therapy not restored by dihydrotestosterone administration [Internet]. Clinical Endocrinology. 2004 ; 60 36-40.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1111/j.1365-2265.2004.01930.x -
Vancouver
Jorge AAL, Souza SCAL, Arnhold IJP, Mendonça BB. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH anlogue therapy not restored by dihydrotestosterone administration [Internet]. Clinical Endocrinology. 2004 ; 60 36-40.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1111/j.1365-2265.2004.01930.x - Variable ACTH-stimulated 17-Hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations
- Absense of duplication on DAX1 gene in patients with 46,XY sex reversal
- Crescimento linear e estatura final em crianças com tumores adrenais predominantemente virilizantes
- Absense of inactivating mutations and deletions of DAX1 gene in SRY negative 46,XX sex-reversed patients
- Heterogeneidade clínica e molecular do hipogonadismo hipogonadotrófico (HH): importância da avaliação do sistema olfatório no diagnóstico diferencial
- Number of CAG repeats in Exon 1 of androgen receptor gene is not related to gender identity in adult patients with male psudohermaphroditism and male transexualism
- Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitibity syndrome in a brazilian cohort: five novel mutations in the androgen receptor gene
- Molecular analysis of SRY gene in Brazilian 46,XX sex reversed patients: absense of SRY sequence in gonadal tissue
- Genotype and phenotype of 25 brazilian subjects with androgen insensitivity syndrome (ais)
- O efeito da hiperandrogenemia severa e prolongada sobre o eixo hipofise -ovário em pacientes portadoras de tumores virilizantes
Informações sobre o DOI: 10.1111/j.1365-2265.2004.01930.x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas